Amgen Inc (NASDAQ:AMGN)

178.24
Delayed Data
As of May 25
 +0.28 / +0.16%
Today’s Change
153.56
Today|||52-Week Range
201.23
+2.50%
Year-to-Date

Today’s Trading

Previous close177.96
Today’s open177.96
Day’s range177.60 - 179.08
Volume1,811,957
Average volume (3 months)4,651,923
Market cap$116.4B
Data as of 4:00pm ET, 05/25/2018

Growth & Valuation

Earnings growth (last year)-73.73%
Earnings growth (this year)+8.58%
Earnings growth (next 5 years)+5.33%
Revenue growth (last year)+0.45%
P/E ratio56.6
Price/Sales5.61
Price/Book5.03

Competitors

 Today’s
change
Today’s
% change
GILDGilead Sciences-0.15-0.22%
BIIBBiogen+1.80+0.63%
ILMNIllumina Inc-4.61-1.70%
----
Data as of 4:00pm ET, 05/25/2018

Financials

Next reporting dateJuly 31, 2018
EPS forecast (this quarter)$3.54
Annual revenue (last year)$22.8B
Annual profit (last year)$2.0B
Net profit margin8.69%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Robert A. Bradway
Executive Vice President-
Operations
Esteban Santos
Corporate headquarters
Thousand Oaks, California

Forecasts